Skopos Labs, Inc. Castle Biosciences Inc Call Options Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CSTL
# of Institutions
192Shares Held
26.7MCall Options Held
9.5KPut Options Held
5K-
Black Rock Inc. New York, NY3.04MShares$48.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$32.8 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.47MShares$23.5 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.27MShares$20.3 Million2.07% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.2MShares$19.2 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $421M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...